| scholarly article | Q13442814 |
| P2093 | author name string | Rong Jin | |
| Guohong Li | |||
| Shiyong Yu | |||
| Mei-Zhen Cui | |||
| Zifang Song | |||
| Jarvis Li | |||
| Adam Y Xiao | |||
| P2860 | cites work | Reduction of atherosclerosis in mice by inhibition of CD40 signalling | Q24316540 |
| The Apoe(-/-) mouse model: a suitable model to study cardiovascular and respiratory diseases in the context of cigarette smoke exposure and harm reduction | Q26747185 | ||
| The Inflammatory Role of Platelets: Translational Insights from Experimental Studies of Autoimmune Disorders | Q28071325 | ||
| Abciximab Reduces Monocyte Tissue Factor in Carotid Angioplasty and Stenting | Q28165701 | ||
| Mechanisms of monocyte recruitment in vascular repair after injury | Q28648014 | ||
| CD40 ligand promotes Mac-1 expression, leukocyte recruitment, and neointima formation after vascular injury | Q30441065 | ||
| Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis | Q30497499 | ||
| Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia | Q33183118 | ||
| Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile | Q33656103 | ||
| Interleukin 1 receptor 1 and interleukin 1β regulate megakaryocyte maturation, platelet activation, and transcript profile during inflammation in mice and humans | Q33804422 | ||
| Platelets and restenosis | Q33862443 | ||
| CD40 is essential in the upregulation of TRAF proteins and NF-kappaB-dependent proinflammatory gene expression after arterial injury | Q34005419 | ||
| Demonstration of all connective tissue elements in a single section; pentachrome stains. | Q34237133 | ||
| Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice | Q35160907 | ||
| Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype | Q35161070 | ||
| The platelet CD40L/GP IIb-IIIa axis in atherothrombotic disease | Q35197406 | ||
| Roles of the kinase TAK1 in CD40-mediated effects on vascular oxidative stress and neointima formation after vascular injury | Q35210912 | ||
| Crucial role of CD40 signaling in vascular wall cells in neointimal formation and vascular remodeling after vascular interventions | Q35621648 | ||
| Platelet PI3Kγ Contributes to Carotid Intima-Media Thickening under Severely Reduced Flow Conditions | Q35656802 | ||
| Directed migration of mouse macrophages in vitro involves myristoylated alanine-rich C-kinase substrate (MARCKS) protein | Q36188854 | ||
| Soluble CD40 ligand induces β 3 integrin tyrosine phosphorylation and triggers platelet activation by outside-in signaling | Q36350146 | ||
| Fractalkine preferentially mediates arrest and migration of CD16+ monocytes | Q36370923 | ||
| The importance of reendothelialization after arterial injury | Q36855689 | ||
| A Novel Protective Function of 5-Methoxytryptophan in Vascular Injury | Q36871106 | ||
| Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases | Q37307308 | ||
| CD154 and its receptors in inflammatory vascular pathologies | Q37413813 | ||
| The CD40/CD40 ligand system: linking inflammation with atherothrombosis | Q37579360 | ||
| Platelets: pleiotropic roles in atherogenesis and atherothrombosis. | Q37776791 | ||
| Platelet-leukocyte interactions in cardiovascular disease and beyond | Q37808902 | ||
| CD40 ligand: a neo-inflammatory molecule in vascular diseases | Q37870280 | ||
| Role of platelets as mediators that link inflammation and thrombosis in atherosclerosis | Q38016490 | ||
| Platelets: key players in vascular inflammation | Q38038134 | ||
| Chemokines and chemokine receptors: positioning cells for host defense and immunity | Q38198156 | ||
| The Role of Platelets in Cardiovascular Disease: Molecular Mechanisms. | Q38860186 | ||
| Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury | Q40703820 | ||
| Platelet-derived interleukin 1 induces human endothelial adhesion molecule expression and cytokine production | Q41851230 | ||
| Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients | Q45248514 | ||
| Enhanced soluble CD40 ligand contributes to endothelial cell dysfunction in vitro and monocyte activation in patients with diabetes mellitus: effect of improved metabolic control. | Q46469540 | ||
| The CD40-TRAF6 axis is the key regulator of the CD40/CD40L system in neointima formation and arterial remodeling | Q47245105 | ||
| CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1. | Q51798890 | ||
| Requirement for CD154 in the progression of atherosclerosis. | Q52536870 | ||
| Platelet CD40 Exacerbates Atherosclerosis by Transcellular Activation of Endothelial Cells and Leukocytes. | Q53192004 | ||
| RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. | Q54014329 | ||
| Soluble CD40 Ligand in Acute Coronary Syndromes | Q58816350 | ||
| Animal Models for Studying Neointima Formation | Q59384939 | ||
| CD40L stabilizes arterial thrombi by a β3 integrin–dependent mechanism | Q63354517 | ||
| Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand | Q73401367 | ||
| Differential cell cycle progression patterns of infiltrating leukocytes and resident cells after balloon injury of the rat carotid artery | Q77350517 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 252-263 | |
| P577 | publication date | 2017-10-13 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Platelet CD40 Mediates Leukocyte Recruitment and Neointima Formation after Arterial Denudation Injury in Atherosclerosis-Prone Mice | |
| P478 | volume | 188 |
| Q47713533 | Cyclic Nucleotide-Directed Protein Kinases in Cardiovascular Inflammation and Growth |
| Q93187340 | Modelling of atherosclerosis in genetically modified animals |
| Q90669023 | PI3Kγ (Phosphoinositide 3-Kinase-γ) Inhibition Attenuates Tissue-Type Plasminogen Activator-Induced Brain Hemorrhage and Improves Microvascular Patency After Embolic Stroke |
Search more.